AIM IMMUNOTECH INC. Payments to Acquire Marketable Securities
AIM IMMUNOTECH INC. (AIM) reported Payments to Acquire Marketable Securities of $91.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-03-27
- AIM IMMUNOTECH INC. payments to acquire marketable securities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for the quarter ending 2025-09-30 was $0.00.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for the quarter ending 2025-06-30 was $0.00.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for the quarter ending 2025-03-31 was $91.00K, a 42.41% decline year-over-year.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for fiscal 2025 was $91.00K, a 74.79% decline from fiscal 2024.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for fiscal 2024 was $361.00K.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for fiscal 2022 was $2.72M, a 87.91% decline from fiscal 2021.
- AIM IMMUNOTECH INC. payments to acquire marketable securities for fiscal 2021 was $22.54M, a 21.07% increase from fiscal 2020.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-03-27 | $91.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $91.00K 10-Q · filed 2025-11-17 | $294.00K derived: sum of 4 quarters · filed 2026-03-27 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $91.00K 10-Q · filed 2025-08-14 | $294.00K derived: sum of 3 quarters · filed 2026-03-27 | $294.00K derived: sum of 4 quarters · filed 2026-03-27 |
| 2025-03-31 | $91.00K 10-Q · filed 2025-05-15 | $294.00K derived: sum of 2 quarters · filed 2026-03-27 | $294.00K derived: sum of 3 quarters · filed 2026-03-27 | $294.00K derived: sum of 4 quarters · filed 2026-03-27 |
| 2024-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $203.00K derived: sum of 2 quarters · filed 2026-03-27 | $203.00K derived: sum of 3 quarters · filed 2026-03-27 | $361.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $158.00K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $158.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $158.00K 10-Q · filed 2025-05-15 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $712.00K 10-Q · filed 2023-08-14 | $1.77M derived: sum of 3 quarters · filed 2023-08-14 | $2.17M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $712.00K 10-Q · filed 2023-05-15 | $1.77M derived: sum of 2 quarters · filed 2023-05-15 | $2.17M derived: sum of 3 quarters · filed 2023-05-15 | $2.72M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.46M derived: sum of 2 quarters · filed 2023-03-31 | $2.00M derived: sum of 3 quarters · filed 2023-08-14 | $2.72M 10-K · filed 2023-03-31 |
| 2022-09-30 | $399.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $941.00K derived: sum of 2 quarters · filed 2023-08-14 | $1.66M 10-Q · filed 2022-11-14 | $22.59M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $542.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.26M 10-Q · filed 2023-08-14 | $22.19M derived: sum of 3 quarters · filed 2023-08-14 | $21.70M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $720.00K 10-Q · filed 2023-05-15 | $21.64M derived: sum of 2 quarters · filed 2023-05-15 | $21.16M derived: sum of 3 quarters · filed 2023-05-15 | $22.10M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $20.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $20.44M derived: sum of 2 quarters · filed 2023-03-31 | $21.38M derived: sum of 3 quarters · filed 2023-03-31 | $22.54M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$485.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $460.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.61M 10-Q · filed 2022-11-14 | $3.06M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $945.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.10M 10-Q · filed 2022-08-15 | $3.54M derived: sum of 3 quarters · filed 2022-08-15 | $13.12M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.15M 10-Q · filed 2022-05-13 | $2.60M derived: sum of 2 quarters · filed 2022-05-13 | $12.17M derived: sum of 3 quarters · filed 2022-05-13 | $9.45M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $11.02M derived: sum of 2 quarters · filed 2022-03-31 | $8.29M derived: sum of 3 quarters · filed 2022-03-31 | $18.61M 10-K · filed 2022-03-31 |
| 2020-09-30 | $9.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.85M derived: sum of 2 quarters · filed 2021-11-15 | $17.17M 10-Q · filed 2021-11-15 | $22.36M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $7.59M 10-Q · filed 2021-08-16 | $12.78M derived: sum of 3 quarters · filed 2021-08-16 | $12.99M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $10.32M 10-Q · filed 2021-05-17 | $15.51M derived: sum of 2 quarters · filed 2021-05-17 | $15.72M derived: sum of 3 quarters · filed 2021-05-17 | $15.14M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $5.40M derived: sum of 2 quarters · filed 2021-03-31 | $4.82M derived: sum of 3 quarters · filed 2021-03-31 | $5.78M 10-K · filed 2021-03-31 |
| 2019-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$372.00K derived: sum of 2 quarters · filed 2020-11-12 | $588.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $379.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $960.00K 10-Q · filed 2020-05-14 | |||
| 2015-09-30 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$2.50M derived: sum of 2 quarters · filed 2015-11-16 | -$2.50M 10-Q · filed 2015-11-16 | -$1.27M derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$54.00K 10-Q · filed 2015-08-12 | $1.17M derived: sum of 3 quarters · filed 2015-08-12 | -$90.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 | $1.22M derived: sum of 2 quarters · filed 2015-05-12 | -$36.00K derived: sum of 3 quarters · filed 2015-11-16 | -$37.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$36.00K derived: sum of 2 quarters · filed 2015-11-16 | -$37.00K derived: sum of 3 quarters · filed 2015-11-16 | $0.00 10-K · filed 2015-03-19 |
| 2014-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$1.26M derived: sum of 2 quarters · filed 2015-11-16 | -$1.22M 10-Q · filed 2015-11-16 | -$1.22M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $36.00K 10-Q · filed 2015-08-12 | $36.00K derived: sum of 3 quarters · filed 2015-08-12 | $36.00K derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | $37.00K 10-Q · filed 2015-05-12 | $37.00K derived: sum of 2 quarters · filed 2015-05-12 | $37.00K derived: sum of 3 quarters · filed 2015-05-12 | $37.00K derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $0.00 derived: sum of 2 quarters · filed 2015-03-19 | $0.00 derived: sum of 3 quarters · filed 2015-03-19 | $0.00 10-K · filed 2015-03-19 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2014-08-08 | $0.00 10-Q · filed 2013-11-08 | $19.25M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | $19.25M derived: sum of 3 quarters · filed 2015-03-19 | $30.71M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $19.25M derived: sum of 2 quarters · filed 2015-03-19 | $30.71M derived: sum of 3 quarters · filed 2015-03-19 | |
| 2012-12-31 | $19.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $30.71M derived: sum of 2 quarters · filed 2015-03-19 | $32.77M 10-K · filed 2015-03-19 | |
| 2012-09-30 | $11.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $13.52M 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | $2.06M 10-Q · filed 2013-08-09 | |||
| 2011-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $7.02M derived: sum of 2 quarters · filed 2014-03-14 | $7.03M derived: sum of 3 quarters · filed 2014-03-14 | $10.20M 10-K · filed 2014-03-14 |
| 2011-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$43.00K derived: sum of 2 quarters · filed 2012-11-02 | $3.13M 10-Q · filed 2012-11-02 | $4.17M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $3.18M 10-Q · filed 2012-08-08 | $4.21M derived: sum of 3 quarters · filed 2013-03-18 | $7.85M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $3.18M 10-Q · filed 2012-05-07 | $4.21M derived: sum of 2 quarters · filed 2013-03-18 | $7.85M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $4.67M derived: sum of 2 quarters · filed 2013-03-18 | $49.89M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $48.86M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $45.22M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |